Pharmaceutical Supply for Indian Army Healthcare Needs

This tender opportunity, identified by Bid Number GEM/2026/B/8061487, is issued by the Department of Military Affairs, under the Ministry of Defence, for the Indian Army. The bid period commences on October 31, 2026, at 2:00 PM and concludes on November 2, 2026, at 2:00 PM. This procurement focuses on a substantial total quantity of 8847 units across a diverse range of critical pharmaceutical items. The specified items include various tablet formulations such as Axitinib 5 mg, Azacitidine 300 mg, Cabozantinib 20 mg, Everolimus 0.5 mg, Nintedanib 100 mg, Nintedanib 150 mg, and Ivosidenib 250 mg. Additionally, the tender encompasses injectable medications, including Denosumab 60 mg Per ml, Leuprolide 22.75 mg, Leuprolide 3.75 mg, and Human Growth Hormone 36 IU (12mg per ml). The issuing authority's office is located in *********, Gurdaspur. This tender represents a significant requirement for a comprehensive supply of essential pharmaceuticals to support military healthcare needs.